Reversing Type 2 Diabetes with GoNo

Thesis for NIH Clinical Study

The indisputable fact remains that food is the #1 cause of Type 2 Diabetes, and most of us believe that food can prevent the disease. However, health insurance companies require empirical actuarial evidence to act. I am elated and proud to announce that we have completed our thesis and study to prove that Food-as-Medicine works AND that the GoNo App is the catalyst to behavioral change and the adoption of healthy food alternatives. 

Please feel free to download our thesis and share any comments. We are pursuing a two-pronged approach for grant funding with both the National Institutes of Health (NIH) and the Small Business Technology Transfer (STTR).

GoNo is the singular scientific food recommendation engine that determines what foods are good or bad for each individual’s medical conditions, wellness goals, and allergies, delivering personalized precision Food-as-Medicine recommendations using unbiased, third-party, peer-approved clinical studies. It considers hundreds of dietary preferences, restrictions, and avoidances along with cultural, religious, sports, and gustatory (tastebud) perception profiles to deliver great foods you love to eat and behavioral changes you want to make.

Dr. Alvin Berger, Ph.D., is the Principal Investigator for the clinical trial and scientific work for GoNo. Dr. Berger is a seasoned senior executive with extensive experience conducting nutritional clinical trials in startup and Fortune 500 companies over the last 25 years (LinkedIn).